NCT06322238
- Conditions
- Drug Metabolism, Poor, CYP2C19-Related, Drug Metabolism, Poor, CYP2D6-Related, Ineffective Drug Action, +2 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
Drug Metabolism, Poor, CYP2C19-Related
Explore clinical trials studying Drug Metabolism, Poor, CYP2C19-Related. Study availability and eligibility vary by location and protocol.
4 public trials
1 recruiting study
Drug Metabolism, Poor, CYP2C19-Related trial results
NCT02378220
- Conditions
- Adverse Drug Events, Adverse Drug Reactions, Chemically-Induced Disorders, +12 more
- Locations
-
- White County Medical Center Home Health Searcy, Arkansas, United States
Completed
YouScript IMPACT Registry
NCT02191358
- Conditions
- Adverse Drug Events, Adverse Drug Reactions, Chemically-Induced Disorders, +13 more
- Locations
-
- Dr. Michael Dao Garden Grove, California, United States
- Kaiser Permanente Colorado Denver, Colorado, United States
- Gill Heart Institute Lexington, Kentucky, United States
- IRC Clinics Towson, Maryland, United States
Completed
Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM
NCT02428660
- Conditions
- CYP2D6 Polymorphism, Chemically-Induced Disorders, Chronic Disease, +12 more
- Locations
-
- VRx Pharmacy Services Salt Lake City, Utah, United States
Related conditions
- Drug Metabolism, Poor, CYP2C19-Related (4)
- Drug Metabolism, Poor, CYP2D6-Related (4)
- Chemically-Induced Disorders (3)
- Cytochrome P450 CYP2C19 Enzyme Deficiency (3)
- Cytochrome P450 CYP2C9 Enzyme Deficiency (3)
- Cytochrome P450 CYP2D6 Enzyme Deficiency (3)
- Drug-Related Side Effects and Adverse Reactions (3)
- Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant (3)